X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Merck Ltd with VENUS REMEDIES - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

MERCK LTD vs VENUS REMEDIES - Comparison Results

MERCK LTD    Change

Merck, the Indian arm of Merck KgaA (Germany), is a relatively smaller player among MNC pharma majors in the country. Merck has two business segments namely Pharmaceuticals and Chemicals. The pharmaceutical business, accounting for 68% of total sales... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    MERCK LTD VENUS REMEDIES MERCK LTD/
VENUS REMEDIES
 
P/E (TTM) x 26.5 -822.3 - View Chart
P/BV x 3.0 0.2 1,232.8% View Chart
Dividend Yield % 1.0 0.0 -  

Financials

 MERCK LTD   VENUS REMEDIES
EQUITY SHARE DATA
    MERCK LTD
Dec-16
VENUS REMEDIES
Mar-16
MERCK LTD/
VENUS REMEDIES
5-Yr Chart
Click to enlarge
High Rs1,060218 486.2%   
Low Rs62382 758.8%   
Sales per share (Unadj.) Rs632.4365.6 173.0%  
Earnings per share (Unadj.) Rs45.71.5 3,076.5%  
Cash flow per share (Unadj.) Rs62.337.9 164.3%  
Dividends per share (Unadj.) Rs11.000-  
Dividend yield (eoy) %1.30-  
Book value per share (Unadj.) Rs388.8382.5 101.6%  
Shares outstanding (eoy) m16.6011.44 145.1%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x1.30.4 324.2%   
Avg P/E ratio x18.4101.0 18.2%  
P/CF ratio (eoy) x13.54.0 341.3%  
Price / Book Value ratio x2.20.4 551.7%  
Dividend payout %24.10-   
Avg Mkt Cap Rs m13,9691,717 813.8%   
No. of employees `0001.61.0 155.2%   
Total wages/salary Rs m1,487324 458.3%   
Avg. sales/employee Rs Th6,631.94,100.7 161.7%   
Avg. wages/employee Rs Th939.2318.0 295.3%   
Avg. net profit/employee Rs Th479.416.7 2,876.4%   
INCOME DATA
Net Sales Rs m10,4984,183 251.0%  
Other income Rs m24220 1,206.0%   
Total revenues Rs m10,7414,203 255.6%   
Gross profit Rs m1,135812 139.9%  
Depreciation Rs m276417 66.1%   
Interest Rs m0380 0.0%   
Profit before tax Rs m1,10235 3,140.2%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m34318 1,896.7%   
Profit after tax Rs m75917 4,464.1%  
Gross profit margin %10.819.4 55.7%  
Effective tax rate %31.151.6 60.4%   
Net profit margin %7.20.4 1,778.6%  
BALANCE SHEET DATA
Current assets Rs m6,4102,771 231.3%   
Current liabilities Rs m8,8281,931 457.1%   
Net working cap to sales %-23.020.1 -114.8%  
Current ratio x0.71.4 50.6%  
Inventory Days Days58125 46.1%  
Debtors Days Days3854 71.4%  
Net fixed assets Rs m1,4065,328 26.4%   
Share capital Rs m166114 145.1%   
"Free" reserves Rs m6,2864,177 150.5%   
Net worth Rs m6,4554,376 147.5%   
Long term debt Rs m01,911 0.0%   
Total assets Rs m8,8288,428 104.7%  
Interest coverage xNM1.1-  
Debt to equity ratio x00.4 0.0%  
Sales to assets ratio x1.20.5 239.6%   
Return on assets %8.64.7 182.6%  
Return on equity %11.80.4 3,026.7%  
Return on capital %17.16.6 258.7%  
Exports to sales %8.30-   
Imports to sales %21.020.5 102.5%   
Exports (fob) Rs m869NA-   
Imports (cif) Rs m2,209858 257.4%   
Fx inflow Rs m9590-   
Fx outflow Rs m2,612858 304.3%   
Net fx Rs m-1,653-858 192.6%   
CASH FLOW
From Operations Rs m1,070469 228.3%  
From Investments Rs m-75029 -2,567.5%  
From Financial Activity Rs m-150-464 32.3%  
Net Cashflow Rs m17135 495.4%  

Share Holding

Indian Promoters % 0.0 32.9 -  
Foreign collaborators % 51.8 0.0 -  
Indian inst/Mut Fund % 18.2 0.2 10,111.1%  
FIIs % 1.0 0.6 172.4%  
ADR/GDR % 0.0 0.0 -  
Free float % 29.1 66.4 43.8%  
Shareholders   28,591 20,121 142.1%  
Pledged promoter(s) holding % 0.0 36.4 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare MERCK LTD With:   PIRAMAL ENTERPRISES  GSK PHARMA  DR. DATSONS LABS  DR. REDDYS LAB  NOVARTIS  

Compare MERCK LTD With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Finishes on a Flat Note; Dr Reddy's & Lupin Surge over 2%(Closing)

Indian share markets continued to trade just above the dotted line in the afternoon session in a lackluster day of trading. At the closing bell, the BSE Sensex closed higher by 33 points.

Related Views on News

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Dr Reddy's: US Pressure Continues to Haunt (Quarterly Results Update - Detailed)

Aug 8, 2017

Profits plunge due to higher raw material costs.

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

The Power of 5 Minutes (The 5 Minute Wrapup)

Jun 16, 2017

Here's what you can expect from The 5 Minute Wrapup in the coming months and years.

More Views on News

Most Popular

A 'Backdoor' to Multibaggers: It's Like Investing in Asian Paints Ten Years Ago(The 5 Minute Wrapup)

Aug 10, 2017

Don't miss these proxy bets on growing companies or in a few years you will be looking back with regret.

The Most Important Innovation in Finance Since Gold Coins(Vivek Kaul's Diary)

Aug 10, 2017

Bill connects the dots...between money and growth, real money and real resources, gold and cryptocurrencies...and between gold, cryptocurrencies, and time.

Signs of Life in the India VIX(Daily Profit Hunter)

Aug 12, 2017

The India VIX is up 36% in the last week. Fear has gone up but is still low by historical standards.

Bitcoin Continues Stellar Rise(Chart Of The Day)

Aug 10, 2017

Bitcoin hits an all-time high, is there more upside left?

5 Steps To Become Financially Independent(Outside View)

Aug 16, 2017

Ensure your financial Independence, and pledge to start the journey towards financial freedom today!

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

MERCK LTD SHARE PRICE


Aug 22, 2017 (Close)

TRACK MERCK LTD

  • Track your investment in MERCK LTD with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MERCK LTD - SANOFI INDIA COMPARISON

COMPARE MERCK LTD WITH

MARKET STATS